Journey Medical (DERM) Annual Income Statement

Annual · GAAP · USD millions
Access DERM quarterly income statements →
This income statement overview for Journey Medical spans from Dec 31 2021 to Dec 31 2025, showing how the company's revenues, expenses, and earnings have changed across reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
2025
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax61.24
Total Revenue61.86
Costs & Expenses
Cost of Goods and Services Sold20.92
Gross Profit40.93
Selling, Administration, Marketing44.37
Depreciation & Amortization4.26
Research and Development Expense0.48
Impairment of Intangible Assets (Excluding Goodwill)0.00
Other Operating Expense / -Income0.00
Total operating costs including COS70.03
Operating income / -loss-8.17
Interest Expense0.00
Net Interest Expense / -Income0.00
Extinguishment of Debt0.00
Foreign Currency Transaction Gain (Loss), before Tax0.09
Other loss / -income3.70
Total costs & expenses73.23
Income & Taxes
Income / -loss before income taxes-11.37
Income taxes expenses / -benefit0.06
Income after income taxes-11.43
Net income / -loss of other equity0.00
Income / -loss from continuing operations-11.43
Net income / -loss-11.43
Income / -loss to shareholder-11.43
EBIT-11.37
EBITD-11.37
EBITDA-6.65
Earnings Per Share
Basic EPS (excl. extra items)-0.47
Basic Net EPS-0.47
Basic shares outstanding (Mill. of Units)24.50
Diluted Net EPS-0.47
Diluted average shares (Mill. of Units)24.50
4 historic quarters locked

Sign in to unlock the full Journey Medical income statement history.

About Journey Medical Corp Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.